Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Compliance Officers Make Good “Whistleblowers” – U.S. Prosecutor Sheehan

Executive Summary

Corporate compliance officers will make up the next wave of "whistleblowers" in health care fraud cases, Philadelphia Associate U.S. Attorney James Sheehan said at the Food & Drug Law Institute Enforcement & Litigation Conference in Washington, D.C. Sept. 22

You may also be interested in...



Rx Compliance Programs May Be Undermined By Federal Investigations

Federal investigators' increasing use of information gathered through internal investigations may undermine the effectiveness of corporate compliance programs, attorney Steven Kowal of Bell Boyd & Lloyd (Chicago) said

Rx Compliance Programs May Be Undermined By Federal Investigations

Federal investigators' increasing use of information gathered through internal investigations may undermine the effectiveness of corporate compliance programs, attorney Steven Kowal of Bell Boyd & Lloyd (Chicago) said

Lilly Evaluating Audit Committee Responsibilities In Light Of New NYSE Rules

Lilly is evaluating the legal and regulatory oversight responsibilities of its audit committee in light of New York Stock Exchange Corporate Governance Rules

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS042521

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel